Published: 2018-12-26

Impacts of transfusion in β-thalassemia major patients receiving multiple blood transfusions

Virendra Singh, Battilal Meena, Naseem A. Bihari, Mahendra Sharma


Background: Beta-thalassemia major is one of major public health problems in India. Thalassemia major is a transfusion-dependent severe anemia and these children experience various problems if the transfusion is inadequate but at the same time repeated blood transfusions are associated with hazards like iron overload.

Methods: This study was conducted at thalassemia ward of S.M.S Hospital and J.K.LON paediatrics Hospital, Jaipur from April 2012 to Nov. 2013. 145 thalassemia patients on transfusion therapy attending outdoor or being admitted were assessed after obtaining due permission from the authorities and consent from the guardian or parents of patients.

Results: Present study comprised 145 beta-thalassemia major patients with 51 (35%) females and 94 (65%) males in which youngest patient is 3 years old and the oldest 33 years. 104 (72%) were Hindus and 41 (28%) were Muslims. Consanguinity was found in a significant proportion 16% (23) of the parents of the patients. 137 (94%) patients had serum ferritin ³1000ng/ml. Out 145 thalassemic patients, 108 (74.5%) have total serum bilirubin >1(mg/dl), 103 (71%) have SGPT level >35IU, 103 (71%) have SGOT level >40IU), 38 (26.2%) have serum alkaline phosphatase level >390 IU, 35 (24.1%) have serum creatinine level >1.6mg/dl, 42 (29%) have serum urea level >45mg/dl, 28 (19.3%) have serum uric acid level >6mg/dl.

Conclusions: It is suggested to revise and devise suitable transfusion regime so that a balance between adequate transfusion and minimum side effects of multiple transfusions is maintained. Systemic effects of multiple transfusions should be rigorously and meticulously studied.


Blood transfusion, Ferritin, Iron chelation, Thalassemia

Full Text:



Patel J, Patel A, Patel J, Kaur A, Patel V. Prevalence of haemoglobinopathies in Gujarat, India: A cross-sectional study. Int J Hematol. 2008;5(1):1-6

De SV. Growth and puberty and its management in thalassemia. Horm Res. 2002;58(Suppl 1):72-9.

World Health Organization: Human genetics programme. Division of communicable disease. community control of hereditary anemia memorandum for a WHO meeting. Bull WHO. 1983;61:63-80.

Manglani M, Lokeshwar MR, Vani VG, Bhatia N, Mhaskar V. ‘NESTROFT’- an effective screening test for b- Thalassemia trait. Indian Pediatrics. 1997;34:703-8.

Verma IC, Choudhry VP, Jain PK. Prevention of thalassemia: A necessity in India. India J Pediatr. 1992;59:649-54.

Yaish HM. Medscape. Fact sheet: Pediatric Thalassemia, 2017. Available at: Accessed 6 August 2007.

Kirti G, Pankaj A. Associated complications in beta thalassemia patients. IOSR J Pharmacy. 2013;3(1):22-5.

Cazzola M, Borgna PC, Locatelli F, Ponchio L, Beguin Y, De Stefano P. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion. 1997;37:135-40.

Peters M, Heijboer H, Smiers F. Diagnosis and management of thalassaemia. BMJ. 2012;344(1):e228.

Shah SJ, Chauhan SC, Rathod HK, Patel AB, Sharma VY. A profile of cases of hemoglobinopathies at a Medical college. National J Med Res. 2012;2(2):137-40.

Ghai OP, Gupta P, Paul VK. Essential Pediatrics. 6th ed. Delhi: CBS Publishers and Distributors; 2005:302-315.

Manchanda SS, Khanna HL. Severe Anemia in childhood. Ind J Child Health. 1961;11:462.

Magotra ML, Phadke MV. Anemia in infancy and childhood. Ind Ped. 1975;12:493-98.

Giri DD, Patra SB, Patel RZ. Hemoglobinopathies in childhood. Ind J Pathol Microbiol. 1984;27(2):81-9.

Coelho G, Setna S, Simmons C. HFE mutation on iron metabolism in beta thalassemia. Ind J Child Health. 1958;7:378.

Shanthi G, Balasubramanyam D, Srinivasan R. Studies on the haematological aspects of beta ()- thalassemia in Tamilnadu. RJPBCS. 2013;4(3):784-90.

Kumar S, Pai RA. Swaminathan MS. Consanguineous marriages and the genetic load due to Iethal genes in Kerala. Ann Humn Genet. 1967;31:141-5.

Radha RDA, Appaji RN, Bittles AH. Inbreeding in the state of Karnataka. South India. Humn Hered. 1982;32:8-10.

Rao PSS. Inharaj SG. Inbreeding in Tamil Nadu, South India. Soc Biol. 1977:24:281-8.

Rao PSS. Religion and the intensitv of inbreeding in Tamil Nadu. South India. Soc Biol. 1983;30:413-22.

Karahanyan E, Stoyanova A, Moumdzhiev I, Ivanov I. Secondary diabetes in children with thalassaemia major (homozygous thalassaemia). Folia Med (Plovdiv). 1994;36:29-34.

Kurtoglu AU, Kurtoglu E, Temizkan AK. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia. Endokrynologia Polska/Polish J Endocrinol Tom. 2012;63(4):260-63.

Thuret I, Pondarré C, Loundou A, Steschenko D, Girot R, Bachir D. Complications and treatment of patients with β-thalassemia in France: Results of the national registry. Haematologica. 2010;95(5):724-29.

Najafipour F. Evaluation of endocrine disorders in patients with thalassemia major. Int J Endocrinol Meta. 2008;2:104-13.

El-Hazmi MA, al-Swailem A, al-Fawaz I, Warsey AS, al-Swailem A. Diabetes mellitus in children suffering from beta-thalassaemia. J Trop Pediatr. 1994;40(5):261-6.

Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Abnormal glucose tolerance in Egyptian betathalassemic patients: possible association with genotyping. Pediatr Diabetes. 2004;5:126-32.

Hoffbrand AV, Pettit JE. Essential hematology. 4th ed. UK: Black Well Science; 2001:71-90.

Hira T, Syeda Amna S. Complications in thalassaemia patients receiving blood tranfusion. J Biomed Sci Res. 2011;3(1):339-46.

Adaay MH, Al-Anzy MM, Al-Samarrai AMH, Al-Tikriti KA, Al-Samarrai FA. Some observations on the occurrence of β-thalassemia in Mosul. Iraqi J Med Sci. 2011;9(3):270-74.

Israa IM, Fadhila S. Assessment of liver functions in thalassaemia. Tikrit J Pharma Sci. 2012;8(1):87-95.

Mohkam M, Shamsian BS, Gharib A, Nariman S, Arzanian MT. Early markers of renal dysfunction in patients with beta-thalassemia major. Pediatri. Nephrol. 2008;23:971-6.

Agarwal MB, Shah S, Vishwanathan C, Rajadhyaksha G, Bhave AA, Dube SR et al. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Ind Pediatr. 1992;29(8):997-1102.

Arankalle VA, Chadha MS, Jha J, Amrapurkar DN, Banerjee K. Prevalence of anti-HCV antibodies in western India. Ind J Med Res. 1995;101:91-3.

Vidja PJ, Vachhani JH, Sheikh SS, Santwani PM. Blood transfusion transmitted infections in multiple blood transfused patients of beta thalassaemia. Ind J Hematol Blood Trans. 2011;27(2):65-9.